SK bioscience appoints new executives
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
The bulk drug plants that have already been commissioned include CDA, para amino phenol, atorvastatin, sulfadiazine, oxcarbazepine, levofloxacin, carbidopa and levodopa
Besides powering the drug discovery efforts, phytopharmaceuticals have a huge potential to create a niche market for itself, thereby helping to expand the bio-economy.
Subscribe To Our Newsletter & Stay Updated